What does CUSIP 206022905 represent in this 13F holders report?

CUSIP 206022905 is the security identifier for 206022905 - CONCERT PHARMACEUTICALS INC - COM - Call used to aggregate holder disclosures.

How many institutions held 206022905 - CONCERT PHARMACEUTICALS INC - COM - Call in Q2 2020?

No institutional holders were reported for 206022905 - CONCERT PHARMACEUTICALS INC - COM - Call in Q2 2020; review adjacent reporting periods for trend context.

CONCERT PHARMACEUTICALS INC - COM - Call

CUSIP: 206022905

Q2 2020 13F Holders as of 30 Jun 2020

Type / Class: Equity / COM
Price per share: $41.67
Number of holders: 0

Quarterly Holders Quick Answers

What is CUSIP 206022905?
CUSIP 206022905 identifies 206022905 - CONCERT PHARMACEUTICALS INC - COM - Call in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2020
Previous quarter: Q1 2020

Recent filing periods for CUSIP 206022905:

Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021

CONCERT PHARMACEUTICALS INC - COM - Call

Q2 2020 13F Holders as of 30 Jun 2020

Quarterly Holders Quick Answers

Related Filing Research

Explore More Reporting Periods

There are no holders of CONCERT PHARMACEUTICALS INC - COM - Call as of Q2 2020.